
Australian precision microbiome company Microba has announced that the first participants in its phase 1 inflammatory bowel disease (IBD) clinical …
Cancer Research UK has produced the first batch of product from its recently-completed biologics manufacturing unit, and hopes to release …
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion

